LDXHF vs ABT: Which Stock is Better?
Side-by-side comparison of Lumos Diagnostics Holdings Limited and Abbott Laboratories in 2026
LDXHF
Lumos Diagnostics Holdings Limited
—
ABT
Abbott Laboratories
$95.15
Key Metrics Comparison
| Metric | LDXHF | ABT | Winner |
|---|---|---|---|
| Market Cap | $26.50M | $154.15B | ABT |
| P/E Ratio | N/A | 24.79 | ABT |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze LDXHF
Full quant analysis
Analyze ABT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is LDXHF or ABT a better investment?
Comparing LDXHF and ABT: Lumos Diagnostics Holdings Limited has a market cap of $26.50M while Abbott Laboratories has $154.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between LDXHF and ABT?
LDXHF (Lumos Diagnostics Holdings Limited) and ABT (Abbott Laboratories) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: LDXHF or ABT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: LDXHF or ABT?
Both LDXHF and ABT show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: LDXHF or ABT?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: LDXHF or ABT?
Abbott Laboratories (ABT) is larger with a market cap of $154.15B compared to $26.50M for LDXHF.
Should I buy LDXHF or ABT in 2026?
Both LDXHF and ABT have investment merit. LDXHF trades at $N/A while ABT trades at $95.15. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between LDXHF and ABT stock?
Key differences: Market Cap ($26.50M vs $154.15B), P/E Ratio (N/A vs 24.8x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy LDXHF or ABT in 2026?
The choice between LDXHF and ABT depends on your investment goals. ABT shows higher revenue growth (0.0%). ABT has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between LDXHF and ABT?
LDXHF (Lumos Diagnostics Holdings Limited) has a market cap of $26.50M, while ABT (Abbott Laboratories) has a market cap of $154.15B. ABT is the larger company by market value.